» Articles » PMID: 20846630

Molecular Imaging of Activated Von Willebrand Factor to Detect High-risk Atherosclerotic Phenotype

Overview
Publisher Elsevier
Date 2010 Sep 18
PMID 20846630
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: We hypothesized that noninvasive molecular imaging of activated von Willebrand factor (vWF) on the vascular endothelium could be used to detect a high-risk atherosclerotic phenotype.

Background: Platelet-endothelial interactions have been linked to increased inflammatory activation and prothrombotic state in atherosclerosis. These interactions are mediated, in part, by platelet glycoprotein (GP) Ibα, suggesting that dysregulated endothelial vWF is a marker for high-risk atherosclerotic disease.

Methods: Microbubbles targeted to activated vWF were prepared by surface conjugation of recombinant GPIbα. Flow-chamber studies were used to evaluate attachment of targeted microbubbles to immobile platelet aggregates bearing activated vWF. Contrast-enhanced ultrasound (CEU) molecular imaging of the aorta from mice was performed: 1) ex vivo after focal crush injury and blood perfusion; and 2) in vivo in mice with advanced atherosclerosis produced by deletion of the low-density lipoprotein receptor and ApoBec-1 editing peptide (LDLR(-/-)/ApoBec-1(-/-)).

Results: In flow-chamber studies, tracer attachment to vWF was >10-fold greater for microbubbles bearing GPIbα compared with control microbubbles (p < 0.01). In the ex vivo aortic injury model, CEU signal enhancement for vWF-targeted microbubbles occurred primarily at the injury site and was 4-fold greater than at noninjured sites (p < 0.05). In LDLR(-/-)/ApoBec-1(-/-) mice, inflammatory cell infiltrates and dense vWF expression on the intact endothelium were seen in regions of severe plaque formation. Scanning electron microscopy demonstrated widespread platelet-endothelial interaction and only few sites of endothelial erosion. On CEU, signal enhancement for vWF-targeted microbubbles was approximately 4-fold greater (p < 0.05) in LDLR(-/-)/ApoBec-1(-/-) compared with wild-type mice. En face aortic microscopy demonstrated regions where platelet adhesion and microbubble attachment colocalized.

Conclusions: Molecular imaging using GPIbα as a targeting moiety can detect the presence of activated vWF on the vascular endothelium. This strategy may provide a means to noninvasively detect an advanced prothrombotic and inflammatory phenotype in atherosclerotic disease.

Citing Articles

Innovative Atherosclerosis Models: Advancing Pathophysiology and Translational Research.

Jiang H, Liao Y, Zhu M, Jiramonai L, Wu H, Zhong Y Research (Wash D C). 2025; 8:0617.

PMID: 40046514 PMC: 11881979. DOI: 10.34133/research.0617.


Removal of endothelial surface-associated von villebrand factor suppresses accelerate datherosclerosis after myocardial infarction.

Ozawa K, Packwood W, Muller M, Qi Y, Xie A, Varlamov O J Transl Med. 2024; 22(1):412.

PMID: 38693516 PMC: 11062912. DOI: 10.1186/s12967-024-05231-6.


Low-density lipoprotein promotes microvascular thrombosis by enhancing von Willebrand factor self-association.

Chung D, Platten K, Ozawa K, Adili R, Pamir N, Nussdorfer F Blood. 2023; 142(13):1156-1166.

PMID: 37506337 PMC: 10541996. DOI: 10.1182/blood.2023019749.


Ibrutinib Inhibits BMX-Dependent Endothelial VCAM-1 Expression and Pro-Atherosclerotic Endothelial Activation and Platelet Adhesion .

Kohs T, Olson S, Pang J, Jordan K, Zheng T, Xie A Cell Mol Bioeng. 2022; 15(3):231-243.

PMID: 35611166 PMC: 9124262. DOI: 10.1007/s12195-022-00723-1.


Contrast-enhanced ultrasound molecular imaging of activated platelets in the progression of atherosclerosis using microbubbles bearing the von Willebrand factor A1 domain.

Tian J, Weng Y, Sun R, Zhu Y, Zhang J, Liu H Exp Ther Med. 2021; 22(1):721.

PMID: 34007330 PMC: 8120515. DOI: 10.3892/etm.2021.10153.


References
1.
Lindner J, Song J, Christiansen J, Klibanov A, Xu F, Ley K . Ultrasound assessment of inflammation and renal tissue injury with microbubbles targeted to P-selectin. Circulation. 2001; 104(17):2107-12. DOI: 10.1161/hc4201.097061. View

2.
Yago T, Lou J, Wu T, Yang J, Miner J, Coburn L . Platelet glycoprotein Ibalpha forms catch bonds with human WT vWF but not with type 2B von Willebrand disease vWF. J Clin Invest. 2008; 118(9):3195-207. PMC: 2518822. DOI: 10.1172/JCI35754. View

3.
Bongers T, de Bruijne E, Dippel D, de Jong A, Deckers J, Poldermans D . Lower levels of ADAMTS13 are associated with cardiovascular disease in young patients. Atherosclerosis. 2009; 207(1):250-4. DOI: 10.1016/j.atherosclerosis.2009.04.013. View

4.
Huo Y, Schober A, Forlow S, Smith D, Hyman M, Jung S . Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat Med. 2002; 9(1):61-7. DOI: 10.1038/nm810. View

5.
Ruggeri Z . Platelets in atherothrombosis. Nat Med. 2002; 8(11):1227-34. DOI: 10.1038/nm1102-1227. View